je.st
news
Tag: preclinical
Digital Pathology Software improves pre-clinical testing efficacy.
2014-09-16 14:30:44| Industrial Newsroom - All News for Today
Intended for toxicological pathologists conducting peer review studies in pre-clinical trials, Aperio PeerReview™ offers barcode-driven automated integration of LIMS data and images as well as customized, specific viewing functionality. Remote access to peer review slides and simultaneous, real-time discussion of non-concordant samples enable pathologists to conduct peer review studies without shipping slides or traveling. This story is related to the following:Electronic Data Interchange (EDI) Software |
Tags: software
digital
testing
pathology
La Jolla Pharmaceutical Announces Positive Pre-Clinical Data For Oral Galectin-3 Inhibitor In Nonalcoholic Steatohepatitis (NASH)
2014-07-30 09:57:01| drugdiscoveryonline Home Page
La Jolla Pharmaceutical Company (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases,recently announced positive pre-clinical data for LJPC-1010 in non-alcoholic steatohepatitis (NASH). LJPC-1010 is a derivative of GCS-100, a carbohydrate inhibitor of galectin-3, which has shown activity in chronic kidney disease in a Phase 2 trial
Tags: data
positive
oral
pharmaceutical
Nuvilex CEO And COO Discuss Preclinical And Clinical Trials, Orphan...
2014-06-05 09:53:20| Logistics - Topix.net
Nuvilex, Inc. President and CEO Kenneth Waggoner and COO Dr. Gerald Crabtree addressed a number of topics associated with the company's pancreatic cancer treatment in an interview with Stock Market Media Group, a research and content development investment relations firm, while the two were attending the American Society of Clinical Oncology ... (more)
Tags: discuss
clinical
ceo
trials
Certara Introduces Pre-Clinical Safety Store To Capture And Validate File-Based Study Data In A CDISC-SEND Database
2014-04-30 09:06:47| drugdiscoveryonline News Articles
Certara, the leading global technology-enabled drug development and drug safety consultancy, announced today the launch of its Pre-clinical Safety Store (PCSS)
Tags: data
store
study
database
Alnylam Presents New Pre-Clinical Data On RNAi Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR)
2014-04-30 06:24:19| drugdiscoveryonline News Articles
Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, recently announced the presentation of new pre-clinical data on RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR)
Tags: data
treatment
presents
targeting